BeOne Medicines (ONC) SVP Henry exercises options and sells 1,660 ADS
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
BeOne Medicines Ltd. SVP and general counsel Lee Chan Henry reported option exercises and share sales. On 02/04/2026, Henry exercised three employee share options covering 6,526, 8,606 and 6,448 ordinary shares, which relate to American Depositary Shares (each ADS represents 13 ordinary shares).
On the same date, Henry sold 664 ADS at $348.79 and 996 ADS at $350.00 under a pre-arranged Rule 10b5-1 trading plan adopted on May 14, 2025, leaving no ADS directly held. Henry continues to directly hold 223,106 ordinary shares and significant remaining options that vest over multi-year schedules, subject to continued service and potential accelerated vesting on certain termination events.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 1,660 shares ($580,197)
Net Sell
9 txns
Insider
Lee Chan Henry
Role
SVP, General Counsel
Sold
1,660 shs ($580K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Share Option (Right to Buy) | 6,526 | $0.00 | -- |
| Exercise | Share Option (Right to Buy) | 8,606 | $0.00 | -- |
| Exercise | Share Option (Right to Buy) | 6,448 | $0.00 | -- |
| Exercise | American Depositary Shares | 502 | $194.47 | $98K |
| Exercise | American Depositary Shares | 662 | $213.32 | $141K |
| Exercise | American Depositary Shares | 496 | $159.03 | $79K |
| Sale | American Depositary Shares | 664 | $348.79 | $232K |
| Sale | American Depositary Shares | 996 | $350.00 | $349K |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Share Option (Right to Buy) — 23,920 shares (Direct);
American Depositary Shares — 502 shares (Direct);
Ordinary Shares — 223,106 shares (Direct)
Footnotes (1)
- Each American Depositary Share represents 13 Ordinary Shares. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025. The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. These securities vest over a four-year period as follows: 25% on July 29, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. These securities vest over a four-year period as follows: 25% on the first anniversary of June 15, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
FAQ
What insider transactions did BeOne Medicines (ONC) report for Lee Chan Henry?
BeOne Medicines reported that SVP and general counsel Lee Chan Henry exercised multiple share options into ordinary shares and corresponding ADS, then sold 1,660 American Depositary Shares on February 4, 2026, in two trades, as disclosed in a Form 4 insider transaction filing.
How many BeOne Medicines ADS did Lee Chan Henry sell, and at what prices?
Lee Chan Henry sold a total of 1,660 American Depositary Shares. The sales were 664 ADS at $348.79 and 996 ADS at $350.00, all executed on February 4, 2026, according to the reported non-derivative transactions in the insider filing.
What BeOne Medicines derivative securities did Lee Chan Henry exercise?
Lee Chan Henry exercised three “Share Option (Right to Buy)” grants on February 4, 2026, covering 6,526, 8,606 and 6,448 ordinary shares. These options had exercise prices represented in ordinary shares and relate to equity awards that vest over four-year schedules.